ALGERT GLOBAL LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$474
-80.9%
56,660
-43.3%
0.02%
-79.6%
Q2 2023$2,482
+351.3%
99,931
+173.2%
0.11%
+315.4%
Q1 2023$550
-75.1%
36,580
-80.4%
0.03%
-78.9%
Q4 2022$2,213
-99.7%
187,029
+72.7%
0.12%
+215.4%
Q3 2022$641,000
+51.2%
108,309
+8.7%
0.04%
+21.9%
Q2 2022$424,000
-33.2%
99,670
+716.4%
0.03%
-82.3%
Q4 2020$635,00012,2080.18%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders